10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 223 filers reported holding 10X GENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.25 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,339,000 | -9.3% | 96,475 | +77.6% | 0.00% | 0.0% |
| Q4 2021 | $8,091,000 | +0.6% | 54,318 | -1.7% | 0.00% | -20.0% |
| Q3 2021 | $8,042,000 | -25.2% | 55,242 | +0.6% | 0.01% | -16.7% |
| Q2 2021 | $10,755,000 | +30.0% | 54,925 | +20.2% | 0.01% | +20.0% |
| Q1 2021 | $8,271,000 | +101.1% | 45,695 | +57.3% | 0.01% | +66.7% |
| Q4 2020 | $4,113,000 | +40.4% | 29,050 | +23.7% | 0.00% | +50.0% |
| Q3 2020 | $2,929,000 | +110.7% | 23,493 | +51.0% | 0.00% | +100.0% |
| Q2 2020 | $1,390,000 | +123.5% | 15,559 | +55.8% | 0.00% | 0.0% |
| Q1 2020 | $622,000 | -52.2% | 9,987 | -41.4% | 0.00% | 0.0% |
| Q4 2019 | $1,300,000 | +43.2% | 17,050 | -5.3% | 0.00% | 0.0% |
| Q3 2019 | $908,000 | – | 18,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |